Recent Posts in bladder cancer Category
Posted on Jun 13, 2011 By Jennifer Williams, Esq.
The French medicines agency (AFSSPS) has suspended the use of the diabetes drug Actos until a European safety review has been conducted. Actos is manufactured by Takeda Pharmaceuticals and the current ...
Continue reading "Actos Use Suspended in France on Bladder Cancer Fears" »
Posted on May 20, 2011 By Jackson Allen & Williams
According to theHeart.org, recent analysis of the safety profile of pioglitazone (Actos) shows an association between Actos and the risk of bladder cancer. The study published in Diabetes Care, was ...
Continue reading "New Analysis Supports Link Between Actos and Bladder Cancer" »
Posted on Sep 20, 2010 By Jackson Allen & Williams
On September 17, 2010, the FDA announced it is conducting an ongoing safety review of the diabetes drug, Actos (pioglitazone). The FDA notified healthcare providers and patients that it is reviewing ...
Continue reading "FDA Investigating Link Between Actos and Bladder Cancer" »